From our survey
Your child says doing okay while you know otherwise; scripts for before the visit, in the room if invited, and when you are worried but not invited.
Parents often see what the exam room misses. Your adult child tells the doctor they are "doing okay." You know they have not left the house on a weekend since spring. That gap between what gets said in a fifteen-minute visit and what is really happening can quietly steer care in the wrong direction.
This piece offers Missouri parents three scripts: one for talking with your adult child before the appointment, one for what to say if they invite you into the room, and one for contacting the doctor's office when you are worried and not invited.
This summer a publisher-funded survey collected answers from 443 adults scattered over ten Midwest states. Asked who could persuade them to try a ketamine-type depression treatment, 74 percent, three out of four, named their own doctor. The share naming family or friends was 18 percent. An ad could sway 2 percent; a podcast host, 1 percent. Those are final, validated results for the general-population sample. For parents and other family of a service member, veteran or first responder, a group of 129, the doctor's share was 75 percent.
The takeaway for parents is not that your voice is small. It is that your voice works best when it helps the doctor see clearly. A doctor who has the whole story can make a recommendation your child will actually trust.
Aim for support, not a verdict.
"I have noticed you seem worn down for a while now. I am not trying to tell you what to do. I just wonder whether your doctor knows how hard it has been."
If they are open to it:
"Would it help if we wrote down the medications you have tried and how they went? Doctors say that list matters a lot."
If they say the medicine is working:
"Okay. If that changes, I am happy to help you find an appointment or drive you. No pressure."
What to avoid in this conversation: diagnosing, naming a specific drug as the answer, or suggesting that treatment is a favor to you. Many people have never heard of the newer options. In the survey, 73 percent had never run across the name Spravato, so leading with it can sound like a sales pitch rather than concern.
Your role is witness, not spokesperson. Let your child speak first. When the doctor turns to you, stick to specific observations.
"I want to add a few things I have seen. Since [month], [he or she] has been sleeping [much more or much less], has stopped [activity], and has missed [work, classes, family events]. It has been going on about [length of time]."
If medication history is incomplete:
"I think [he or she] was also on [medication] around [year]. It did not seem to help, and there were side effects like [example]."
Then hand it back:
"I am here to support whatever you two decide. What would you suggest as the next step?"
If the doctor raises a newer treatment or a psychiatry referral, useful follow-up questions include:
Once your child is an adult, privacy law generally prevents the doctor from sharing information with you without their written permission. It does not prevent you from sharing information with the doctor. You can call or send a message through the office.
"My name is [name]. I am the parent of your patient [full name, date of birth]. I understand you cannot share anything with me. I want to pass along something I think the doctor should know before the next visit. Over the past [time], I have seen [specific changes]. I am concerned it is more serious than [he or she] may be saying."
Stick to facts, not treatment demands. If you have any safety concerns, say so directly, and see the crisis information at the end of this article.
Coverage and convenience drive decisions. Insurance coverage sat among the two leading provider priorities for 85 percent of respondents; nearness to home followed at 43 percent.
Spravato's active ingredient is esketamine. The FDA approved this nasal spray for adults who have not found enough relief in ordinary antidepressants, and it is only administered in certified clinics with observation afterward and is not approved for anyone under 18. IV ketamine is off-label for depression. At-home ketamine sold through telehealth is off-label and less supervised. Only a clinician can decide what fits your child.
You also have a lot of company. The survey found 72 percent of respondents had either struggled themselves or watched someone close struggle with depression, anxiety, or PTSD that outlasted every standard prescription.
Nothing in this article is medical advice, and nobody can promise a treatment will work.
If you believe your child is at risk of suicide, you need nobody's permission to act. Phone or text 988 to reach a Suicide and Crisis Lifeline counselor at any hour, or dial 911 if you think harm is imminent.
Commissioned and financed by the publisher, this survey ran with Pollfish panelists until June 23, 2026, and 443 people aged 18 to 64 answered, from Ohio, Wisconsin, Minnesota, Iowa, Illinois, Indiana, Missouri, Oklahoma, Kansas, and Nebraska. Parents in general were not broken out as a group. The numbers are final; Pollfish completed its validation of the panel.